Does VEDOLIZUMAB Cause Squamous cell carcinoma? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Squamous cell carcinoma have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.1% of all adverse event reports for VEDOLIZUMAB.
34
Reports of Squamous cell carcinoma with VEDOLIZUMAB
0.1%
of all VEDOLIZUMAB reports
2
Deaths
2
Hospitalizations
How Dangerous Is Squamous cell carcinoma From VEDOLIZUMAB?
Of the 34 reports, 2 (5.9%) resulted in death, 2 (5.9%) required hospitalization.
Is Squamous cell carcinoma Listed in the Official Label?
Yes, Squamous cell carcinoma is listed as a known adverse reaction in the official FDA drug label for VEDOLIZUMAB.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Squamous cell carcinoma?
ADALIMUMAB (456)
RUXOLITINIB (413)
TACROLIMUS (327)
INFLIXIMAB (313)
RITUXIMAB (313)
LENALIDOMIDE (304)
PREDNISONE (267)
RANITIDINE (260)
CYCLOSPORINE (254)
METHOTREXATE (252)
Which VEDOLIZUMAB Alternatives Have Lower Squamous cell carcinoma Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB